Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul;8(3):146-151.
doi: 10.1177/1941874417749379. Epub 2018 Jan 17.

Neurologic Complications of Acute Posterior Multifocal Placoid Pigment Epitheliopathy: A Case Series of 4 Patients

Affiliations

Neurologic Complications of Acute Posterior Multifocal Placoid Pigment Epitheliopathy: A Case Series of 4 Patients

Melissa Tsuboyama et al. Neurohospitalist. 2018 Jul.

Abstract

Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is a self-limited idiopathic inflammatory ophthalmologic condition with characteristic funduscopic and fluorescein angiography findings. It is typically characterized by a flu-like prodrome followed by monocular or binocular vision loss. Often, prognosis is excellent with complete or near-complete recovery of vision. Rarely, however, APMPPE is associated with neurologic complications, including meningitis, cerebral vasculitis, and stroke. Treatment in patients with central nervous system (CNS) involvement involves steroids and ultimately other immunosuppressive therapy, as there can be significant resulting morbidity and mortality otherwise. Evidence or guidelines regarding duration of treatment are lacking. We present 4 patients diagnosed with APMPPE who demonstrate the spectrum of neurologic sequelae associated with APMPPE. The first 2 cases highlight cerebrospinal fluid lymphocytic pleocytosis as an indicator of active CNS inflammation and the potential utility of serial lumbar punctures (LPs) to guide treatment duration. Cases 3 and 4 demonstrate the neurovascular complications seen in CNS vasculitis. Case 4 also highlights the potential use of magnetic resonance vessel wall imaging (VWI) as a noninvasive means for disease surveillance and treatment guidance. This case series emphasizes the importance of recognition by neurologists of APMPPE as an entity associated with strokes and cerebral vasculitis in order to provide appropriate and timely treatment. Active CNS inflammation warrants continued aggressive immunosuppressant treatment, and we propose that serial LPs and/or magnetic resonance VWIs may be effective tools to guide disease surveillance and subsequent treatment duration.

Keywords: cerebral vascular disease; headache; meningitis; uveitis; vasculitis.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Scagnelli serves as a consultant for Teva Pharmaceutics, Novartis Pharmaceuticals, Biogen IDEC, and Sanofi-Genzyme. Dr Holloway serves as a consultant for Milliman Inc in reviewing practice guidelines.

Figures

Figure 1.
Figure 1.
Ophthalmologic findings for case 1 (A-C) and case 2 (D-F). A, Fundus photograph of the left eye showing multiple coalescing creamy white lesions at the level of the retinal pigmented epithelium (RPE). B, Fluorescein angiography of the left eye in early arteriovenous phase showing hypofluorescence. C, Fluorescein angiography of the left eye in late arteriovenous phase showing hyperfluorescence. D, Fundus photograph of the right eye showing multiple coalescing creamy white lesions at the level of the RPE. E, Fluorescein angiography of the right eye in early arteriovenous phase showing hypofluorescence. F, Fluorescein angiography of the right eye in late arteriovenous phase showing hyperfluorescence.
Figure 2.
Figure 2.
Neuroradiographic findings in case 3 (A-C) and case 4 (D-G). A, Conventional cerebral angiography reveals decreased flow and vascular beading of the right posterior cerebral artery (yellow arrows). B, Coronal reformatted computed tomography angiography shows diminutive basilar circulation and dilation of collateral vascular channels (yellow circle). C, Magnetic resonance diffusion-weighted imaging (DWI) shows ischemic infarctions throughout the posterior circulation consistent with catastrophic vasculitis (yellow arrows). D, Magnetic resonance vessel wall imaging (VWI) shows concentric perivascular enhancement consistent with vasculitis (orange arrow). E, Follow-up VWI shows resolution of perivascular enhancement with immunosuppressive therapy at 5-month follow-up. F, Vessel wall imaging shows persistent perivascular enhancement of the left middle cerebral artery after 5 months of immunosuppression (orange arrow). G, Diffusion-weighted imaging shows ischemic infarction in the left middle cerebral artery consistent with a vasculitic infarct (orange arrow).

References

    1. Gass JD. Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol. 1968;80(2):177–185. - PubMed
    1. O’Halloran HS, Berger JR, Lee WB, et al. Acute multifocal placoid pigment epitheliopathy and central nervous system involvement: nine new cases and a review of the literature. Ophthalmology. 2001;108(5):861–868. - PubMed
    1. Algahtani H, Alkhotani A, Shirah B. Neurological manifestations of acute posterior multifocal placoid pigment epitheliopathy. J Clin Neurol. 2016;12(4):460–467. - PMC - PubMed
    1. Luneau K, Newman NJ, Srivastava S, Biousse V. A case of acute posterior multifocal placoid pigment epitheliopathy with recurrent stroke. J Neuroophthalmol. 2009;29(2):111–118. - PubMed
    1. Matamala JM, Feuerhake W, Verdugo R. Delayed recurrent stroke in a young patient with acute posterior multifocal placoid pigment epitheliopathy. J Stroke Cerebrovasc Dis. 2013;22(8):e630–e634. - PubMed

LinkOut - more resources